Bi Qu

Bi Qu

Auto-generated profile, based on publicly available information

Bi Qu

Department of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YZYu Zhao
Yu Zhao
XDXin Dong
Xin Dong
ZWZhi Wang
Zhi Wang
RDRui Dong
Rui Dong
RBRen Bu
Ren Bu
BQBi Qu
Bi Qu
Modified Tabusen-2 decoction (MTBD) is traditional Chinese Mongolia medicine, mainly used to treat osteoporosis. However, the precise material basis of this prescription is not yet fully elucidated. Herein, we establish an HPLC-Q-Exactive MS/MS spectrometer method with four-step characteristic ion filtering (FSCIF) strategy to quickly and effectively identify the structural features of MTBD and determine the representative compounds content. The FSCIF strategy included database establishment, characteristic ions summarization, neutral loss fragments screening, and secondary mass spectrum fragment matching four steps. By using this strategy, a total of 143 compounds were unambiguously or tentatively annotated, including 5 compounds which were first reported in MTBD. Nineteen representative components were simultaneously quantified with the HPLC-Q-Exactive MS/MS spectrometer, and it is suitable for eight batches of MTBD. Methodology analysis showed that the assay method had good repeatability, accuracy, and stability. The method established above was successfully applied to assess the quality of MTBD extracts. Collectively, our findings enhance our molecular understanding of the MTBD formulation and will allow us to control its quality in a better way. At the same time, this study can promote the development and utilization of ethnic medicine.

29 October 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
ZWZhi Wang
Zhi Wang
BQBi Qu
Bi Qu
SGShu Guo
Shu Guo
JLJie Liu
Jie Liu
YTYuxin Tian
Yuxin Tian
XDXin Dong
Xin Dong
Background/Objectives: Postmenopausal osteoporosis (PMOP) and kidney-yang deficiency (KYD) are major kidney–bone axis disorders with a growing public health burden, yet current therapies are largely single-target and fail to address the coordinated dysfunction of the renal and skeletal systems. Modified Tabusen-2 (MT-2), a multi-herb Mongolian formula whose constituent herbs contain natural bioactive compounds with reported antioxidant and anti-inflammatory activities, reportedly improves both conditions; however, the shared molecular mechanism underlying its dual efficacy remains undefined, hindering its standardization and clinical translation. Methods: We integrated untargeted metabolomics, network pharmacology, targeted LC-MS/MS-based steroid hormone quantification, and qRT-PCR in rat models of hydrocortisone-induced KYD and ovariectomy-induced PMOP treated with MT-2 at high, medium, or low doses for 8 weeks. Results: MT-2 significantly alleviated pathological phenotypes and normalized serum biomarkers in both models. Network pharmacology and metabolomics converged on steroid hormone biosynthesis as the shared core pathway, and targeted quantification confirmed that seven serum steroid hormones were significantly dysregulated (p < 0.05) and effectively reversed by MT-2. qRT-PCR further showed that STAT3 and TP53, transcriptional hubs responsive to oxidative stress and inflammatory signaling, were significantly upregulated in disease groups (p < 0.05) and downregulated after MT-2 treatment. Conclusions: These findings provide molecular evidence supporting the “kidney governing bones” theory and suggest that MT-2 acts through coordinated regulation of steroid hormone biosynthesis and the STAT3/TP53 axis, supporting MT-2 as a multi-target natural bioactive candidate for kidney–bone axis disorders.